Anti-Hu paraneoplastic syndrome presenting as bilateral sixth cranial nerve palsies

Journal of Neuro-Ophthalmology

Volumn 25, Issue 2, 2005, Pages 101-104

  Hammam, Tarek ^a,b   McFadzean, Robert M ^a   Ironside, James W ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; FLUOROURACIL; HU ANTIBODY; HUMAN IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; UNCLASSIFIED DRUG;

ABDUCENS NERVE PARALYSIS; ADULT; ANTI HU PARANEOPLASTIC SYNDROME; ANTIBODY DETECTION; ARTICLE; ATAXIA; BREAST CANCER; BULBAR PARALYSIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIPLOPIA; FEMALE; HUMAN; MAMMOGRAPHY; MASTECTOMY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL;

ABDUCENS NERVE DISEASES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOANTIBODIES; BRAIN STEM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIPLOPIA; ENCEPHALITIS; FATAL OUTCOME; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SIMPLE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARANEOPLASTIC POLYNEUROPATHY; RNA-BINDING PROTEINS; SYNDROME;

EID: 20344388299     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WNO.0000165103.01237.F1     Document Type: Article

References (21)

1. Inuzuki T. Autoantibodies in paraneoplastic neurologic syndrome. Am J Med Sci 2000;319:217-26.
2. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy. A clinical study of 71 patients. Medicine 1992;71:59-72.
3. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurologic syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40.
4. Younger DS, Dalmau J, Inghirami G, et al. Anti-Hu-associated peripheral nerve and muscle microvasculitis. Neurology 1994;44: 181-3.
5. Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol 1999;56:405-8.
6. Wilkinson PC, Zeromski J. Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain 1965;88:529-83.
7. Grisold W, Drlicek M. Paraneoplastic neuropathy. Curr Opin Neurol 1999;12:617-25.
8. Carpentier AF, Rosenfeld MR, Delattre JY, et al. DNA vaccination with HuD inhibits growth of neuroblastoma in mice. Clin Cancer Res 1998;4:2819-24.
9. Rawland LP. Paraneoplastic syndromes. Merritt's neurology, 20th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:893-6.
10. Nath U, Grant R. Neurological paraneoplastic syndromes. J Clin Pathol 1997;50:975-80.
11. Casas Parera I, Fischman D, Paz L, et al. [Paraneoplastic neuropathy with positive anti Hu]. Medicina (B Aires) 1998;58: 197-201.
12. Sutton IJ, Barnett MH, Watson JD, et al. Paraneoplastic brainstem encephalitis and anti-Ri antibodies. J Neurol 2002;249:1597-8.
13. Benke T, Wagner M, Pallua AK, et al. Long-term cognitive and MRI findings in a patient with paraneoplastic limbic encephalitis. J Neuro-Oncol. 2004;66:217-24.
14. Grant R. What the general neurologist needs to know about the paraneoplastic syndromes. Practical Neurol 2002;2:318-27.
15. Voltz R. Paraneoplastic neurologic syndromes: an update on diagnosis, pathogensis, and therapy. Lancet Neurol 2002;1:294-305.
16. Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993; 341:21-2.
17. Posner JB. Paraneoplastic syndromes. In: Posner JB, ed. Neurologic complications of cancer. Contemporary Neurological series. Philadelphia: FA Davis; 1995:353-85.
18. Graus F, Dalmau J, Rene R, et al. Anti-Hu antibodies in patients with small cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997;15:2866-72.
19. Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124:1138-48.
20. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998;50:652-7.
21. Antoine JC, Cinotti L, Tilikete C, et al. (18F) flourodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurologic syndrome and anti-Hu antibodies. Ann Neurol 2000;48:105-8.